Jim O’Donoghue

Views & Analysis

The pharma industry has been talking about the healthcare sector's move to value-based care for some time.

News

Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.